-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BfsmWxbtWWuEqa1m8CEAyigUSc9rcNZrM3ygsvUsY5J+vHOuVJppEHPULz7JQH2q RBg73/Izo0imbN9kVx+kjA== 0000950168-98-000415.txt : 19980217 0000950168-98-000415.hdr.sgml : 19980217 ACCESSION NUMBER: 0000950168-98-000415 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980212 SROS: NASD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-48083 FILM NUMBER: 98534462 BUSINESS ADDRESS: STREET 1: 3151 17TH ST EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 SC 13G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Pharmaceutical Product Development, Inc. ________________________________________________________________________________ (Name of Issuer) Common Stock ________________________________________________________________________________ (Title of Class of Securities) 717124101 ________________________________________________________________________________ (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP Number 717124101 Page 2 of 4 ________________________________________________________________________________ 1. Name of Reporting Person S.S. or I.R.S. Identification No. of Above Person Fredric N. Eshelman ________________________________________________________________________________ 2. Check the Appropriate Box if a Member of a Group (See Instructions) Not Applicable ________________________________________________________________________________ 3. SEC Use Only ________________________________________________________________________________ 4. Citizenship or Place of Organization United States ________________________________________________________________________________ 5. Sole Voting Power Number of 3,095,878 Shares __________________________________________________ Beneficially 6. Shared Voting Power Owned By 0 Each __________________________________________________ Reporting 7. Sole Dispositive Power Person With 3,095,878 __________________________________________________ 8. Shared Dispositive Power 0 ________________________________________________________________________________ 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,095,878 ________________________________________________________________________________ 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) Not Applicable ________________________________________________________________________________ 11. Percent of Class Represented by Amount in Row (9) 13.7% ________________________________________________________________________________ 12. Type of Reporting Person (See Instructions) IN Page 3 of 4 Item 1. Issuer (a) Pharmaceutical Product Development, Inc. (b) 3151 17th Street Extension Wilmington, North Carolina 28412 Item 2. Person Filing (a) Fredric N. Eshelman (b) Pharmaceutical Product Development, Inc. 3151 17th Street Extension Wilmington, North Carolina 28412 (c) See Row (4) on Page 2 (d) See Cover Page (e) See Cover Page Item 3. Filing Pursuant to Rules 13d-1(b) or 13d-2(b) Not Applicable Item 4. Ownership (a) See Row (9) on Page 2 (b) See Row (11) on Page 2 (c) The Reporting Person retains sole voting and dispositive power of all shares. Item 5. Ownership of Five Percent or Less of a Class Not Applicable Item 6. Ownership of More than Five Percent on Behalf of Another Person Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not Applicable Item 8. Identification and Classification of Members of the Group Not Applicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification Not Applicable Page 4 of 4 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 1998 Date /s/ Fredric N. Eshelman Signature Fredric N. Eshelman Name/Title -----END PRIVACY-ENHANCED MESSAGE-----